Catecholaminergic based therapies for functional recovery after TBI

Brain Research

Volumn 1640, Issue , 2016, Pages 15-35

  Osier, Nicole D ^a,d   Dixon, C Edward ^a,b,c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c VA Pittsburgh Healthcare System   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Catecholamine; Dopamine; Epinephrine; Norepinephrine; Therapy; Traumatic brain injury

Indexed keywords

ADRENALIN; AMANTADINE; AMFEBUTAMONE; AMITRIPTYLINE; AMPHETAMINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BROMOCRIPTINE; CLOZAPINE; DESIPRAMINE; DONEPEZIL; DOPAMINE; ESCITALOPRAM; FLUOXETINE; HALOPERIDOL; LISURIDE; METHAMPHETAMINE; METHYLPHENIDATE; MILNACIPRAN; NORADRENALIN; PRAMIPEXOLE; PRAZOSIN; RISPERIDONE; SERTRALINE; VENLAFAXINE; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; CATECHOLAMINE; CATECHOLAMINE RECEPTOR; NEUROPROTECTIVE AGENT;

BRAIN PERFUSION; CASE FATALITY RATE; CATECHOLAMINERGIC SYSTEM; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); COGNITIVE DEFECT; CONTINUOUS INFUSION; DOSE RESPONSE; DRUG BINDING; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MECHANISM; FUNCTIONAL STATUS; HUMAN; LOADING DRUG DOSE; MAINTENANCE THERAPY; NONHUMAN; OUTCOME ASSESSMENT; PARKINSON DISEASE; PRECLINICAL STUDY; PRIORITY JOURNAL; REVIEW; TRAUMATIC BRAIN INJURY; TREATMENT DURATION; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN INJURIES, TRAUMATIC; CONVALESCENCE; DRUG EFFECTS; METABOLISM; PHYSIOLOGY;

ANIMALS; BRAIN INJURIES, TRAUMATIC; CATECHOLAMINES; HUMANS; NEUROPROTECTIVE AGENTS; NEUROTRANSMITTER AGENTS; RECEPTORS, CATECHOLAMINE; RECOVERY OF FUNCTION;

EID: 84951951974     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2015.12.026     Document Type: Review

References (206)

1. Abi-Dargham, A., Moore, H., Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia. Neuroscientist 9 (2003), 404–416.
2. Alexander, G.E., Crutcher, M.D., Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci. 13 (1990), 266–271.
3. Arciniegas, D., Topkoff, J., Silver, J., Neuropsychiatric aspects of traumatic brain injury. Curr. Treat. Options Neurol. 2 (2000), 169–186.
4. Armentero, M.-T., Fancellu, R., Nappi, G., Blandini, F., Dopamine receptor agonists mediate neuroprotection in malonate-induced striatal lesion in the rat. Exp. Neurol. 178 (2002), 301–305.
5. Armstead, W.M., Riley, J., Vavilala, M.S., Dopamine prevents impairment of autoregulation after traumatic brain injury in the newborn pig through inhibition of Up-regulation of endothelin-1 and extracellular signal-regulated kinase mitogen-activated protein kinase. Pediatr. Crit. Care Med. 14 (2013), e103–e111, 10.1097/PCC.0b013e3182712b44.
6. Ashman, T.A., Cantor, J.B., Gordon, W.A., Spielman, L., Flanagan, S., Ginsberg, A., Engmann, C., Egan, M., Ambrose, F., Greenwald, B., A randomized controlled trial of sertraline for the treatment of depression in persons with traumatic brain injury. Arch. Phys. Med. Rehabil. 90 (2009), 733–740, 10.1016/j.apmr.2008.11.005.
7. Baldo, B.A., Kelley, A.E., Discrete neurochemical coding of distinguishable motivational processes: insights from nucleus accumbens control of feeding. Psychopharmacology 191 (2007), 439–459, 10.1007/s00213-007-0741-z.
8. Bales, J., Wagner, A., Kline, A., Dixon, C., Persistent cognitive dysfunction after traumatic brain injury: a dopamine hypothesis. Neurosci. Biobehav. Rev. 33 (2009), 981–1003, 10.1016/j.neubiorev.2009.03.011.
9. Baños, J.H., Novack, T.A., Brunner, R., Renfroe, S., Lin, H.-Y., Meythaler, J., Impact of early administration of sertraline on cognitive and behavioral recovery in the first year after moderate to severe traumatic brain injury. J. Head Trauma Rehabil. 25 (2010), 357–361, 10.1097/HTR.0b013e3181d6c715.
10. Barbay, S., Nudo, R.J., The effects of amphetamine on recovery of function in animal models of cerebral injury: a critical appraisal. NeuroRehabilitation 25 (2009), 5–17, 10.3233/NRE-2009-0495.
11. Beart, P.M., Adrenaline The cryptic central catecholamine. Trends Neurosci. 2 (1979), 295–297, 10.1016/0166-2236(79)90115-2.
12. Berridge, C.W., Neural substrates of psychostimulant-induced arousal. Neuropsychopharmacology 31 (2006), 2332–2340, 10.1038/sj.npp.1301159.
13. Binder, L.M., Persisting symptoms after mild head injury: a review of the postconcussive syndrome. J. Clin. Exp. Neuropsychol. 8 (1986), 323–346, 10.1080/01688638608401325.
14. Bogner, J., Barrett, R.S., Hammond, F.M., Horn, S.D., Corrigan, J.D., Rosenthal, J., Beaulieu, C.L., Waszkiewicz, M., Shea, T., Reddin, C.J., Cullen, N., Giuffrida, C.G., Young, J., Garmoe, W., Predictors of agitated behavior during inpatient rehabilitation for traumatic brain injury. Arch. Phys. Med. Rehabil. 96 (2015), S274–S281.e4, 10.1016/j.apmr.2015.04.020.
15. Bramlett, H.M., Dietrich, W.D., Quantitative structural changes in white and gray matter 1 year following traumatic brain injury in rats. Acta Neuropathol. 103 (2002), 607–614, 10.1007/s00401-001-0510-8.
16. Brustolim, D., Ribeiro-dos-Santos, R., Kast, R.E., Altschuler, E.L., Soares, M.B.P., A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice. Int. Immunopharmacol. 6 (2006), 903–907, 10.1016/j.intimp.2005.12.007.
17. Calipari, E.S., Ferris, M.J., Amphetamine mechanisms and actions at the dopamine terminal revisited. J. Neurosci. 33 (2013), 8923–8925, 10.1523/JNEUROSCI.1033-13.2013.
18. Cantor, J.B., Gordon, W., Gumber, S., What is post TBI fatigue?. NeuroRehabilitation 32 (2013), 875–883, 10.3233/NRE-130912.
19. Capone-Neto, A., Rizoli, S.B., Linking the chain of survival: trauma as a traditional role model for multisystem trauma and brain injury. Curr. Opin. Crit. Care 15 (2009), 290–294, 10.1097/MCC.0b013e32832e383e.
20. Castriotta, R.J., Murthy, J.N., Sleep disorders in patients with traumatic brain injury: a review. CNS. CNS Drugs 25 (2011), 175–185, 10.2165/11584870-000000000-00000.
21. Centers for Disease Control and Prevention, 2015. Traumatic brain injury in the United States: fact sheet [WWW Document]. Inj. Prev. Control Trauma Brain Inj. URL 〈http://www.cdc.gov/traumaticbraininjury/get_the_facts.html〉 (accessed 9.29.15).
22. Centonze, D., Gubellini, P., Picconi, B., Calabresi, P., Giacomini, P., Bernardi, G., Unilateral dopamine denervation blocks corticostriatal LTP. J. Neurophysiol. 82 (1999), 3575–3579.
23. Chandler, M.C., Barnhill, J.L., Gualtieri, C.T., Amantadine for the agitated head-injury patient. Brain Inj. 2 (1988), 309–311.
24. Chen, L., Bohanick, J.D., Nishihara, M., Seamans, J.K., Yang, C.R., Dopamine D1/5 receptor-mediated long-term potentiation of intrinsic excitability in rat prefrontal cortical neurons: Ca2+-dependent intracellular signaling. J. Neurophysiol. 97 (2007), 2448–2464, 10.1152/jn.00317.2006.
25. Chudasama, Y., Nathwani, F., Robbins, T.W., D-Amphetamine remediates attentional performance in rats with dorsal prefrontal lesions. Behav. Brain Res. 158 (2005), 97–107, 10.1016/j.bbr.2004.08.011.
26. Ciaranello, R.D., Barchas, R.E., Byers, G.S., Stemmle, D.W., Barchas, J.D., Enzymatic synthesis of adrenaline in mammalian brain. Nature 221 (1969), 368–369.
27. Cools, A.R., Ellenbroek, B., Heeren, D., Lubbers, L., Use of high and low responders to novelty in rat studies on the role of the ventral striatum in radial maze performance: effects of intra-accumbens injections of sulpiride. Can. J. Physiol. Pharmacol. 71 (1993), 335–342.
28. Cosentino, M., Marino, F., Adrenergic and dopaminergic modulation of immunity in multiple sclerosis: teaching old drugs new tricks?. J. Neuroimmune Pharmacol. 8 (2013), 163–179, 10.1007/s11481-012-9410-z.
29. Cotton, B.A., Snodgrass, K.B., Fleming, S.B., Carpenter, R.O., Kemp, C.D., Arbogast, P.G., Morris, J.A., Beta-blocker exposure is associated with improved survival after severe traumatic brain injury. J. Trauma-Inj. Infect. Crit. Care, 2007, 10.1097/TA.0b013e31802d02d0.
30. Dalley, J.W., Roiser, J.P., Dopamine, serotonin and impulsivity. Neuroscience 215 (2012), 42–58, 10.1016/j.neuroscience.2012.03.065.
31. Dhillon, H.S., Dose, J.M., Prasad, R.M., Amphetamine administration improves neurochemical outcome of lateral fluid percussion brain injury in the rat. Brain Res. 804 (1998), 231–237.
32. Di Chiara, G., Bassareo, V., Reward system and addiction: what dopamine does and doesn׳t do. Curr. Opin. Phamacol 7 (2007), 69–76, 10.1016/j.coph.2006.11.003.
33. Di Gennaro, J.L., MacK, C.D., Malakouti, A., Zimmerman, J.J., Armstead, W., Vavilala, M.S., Use and effect of vasopressors after pediatric traumatic brain injury. Dev. Neurosci. 32 (2011), 420–430, 10.1159/000322083.
34. Dixon, C., Kraus, M., Kline, A., Ma, X., Yan, H., Griffith, R., Wolfson, B., Marion, D., Amantadine improves water maze performance without affecting motor behavior following traumatic brain injury in rats. Restor. Neurol. Neurosci. 14 (1999), 285–294.
35. Donnemiller, E., Brenneis, C., Wissel, J., Scherfler, C., Poewe, W., Riccabona, G., Wenning, G.K., Impaired dopaminergic neurotransmission in patients with traumatic brain injury: a SPECT study using 123I-beta-CIT and 123I IBZM. Eur. J. Nucl. Med. 27 (2000), 1410–1414.
36. Du, F., Li, R., Huang, Y., Li, X., Le, W., Dopamine D3 receptor-preferring agonists induce neurotrophic effects on mesencephalic dopamine neurons. Eur. J. Neurosci. 22 (2005), 2422–2430, 10.1111/j.1460-9568.2005.04438.x.
37. Dunn-Meynell, A.A., Hassanain, M., Levin, B.E., Norepinephrine and traumatic brain injury: a possible role in post-traumatic edema. Brain Res. 800 (1998), 245–252, 10.1016/S0006-8993(98)00524-1.
38. Dyer, K.F.W., Bell, R., McCann, J., Rauch, R., Aggression after traumatic brain injury: analysing socially desirable responses and the nature of aggressive traits. Brain Inj. 20 (2006), 1163–1173, 10.1080/02699050601049312.
39. Ekdahl, C.T., Kokaia, Z., Lindvall, O., Brain inflammation and adult neurogenesis: the dual role of microglia. Neuroscience 158 (2009), 1021–1029, 10.1016/j.neuroscience.2008.06.052.
40. Elsworth, J.D., Roth, R.H., Dopamine synthesis, uptake, metabolism, and receptors: relevance to gene therapy of Parkinson׳s disease. Exp. Neurol. 144 (1997), 4–9, 10.1006/exnr.1996.6379.
41. Failla, M.D., Burkhardt, J.N., Miller, M.A., Scanlon, J.M., Conley, Y.P., Ferrell, R.E., Wagner, A.K., Variants of SLC6A4 in depression risk following severe TBI. Brain Inj. 27 (2013), 696–706, 10.3109/02699052.2013.775481.
42. Färber, K., Kettenmann, H., Physiology of microglial cells. Brain Res. Rev. 48 (2005), 133–143, 10.1016/j.brainresrev.2004.12.003.
43. Feeney, D.M., Gonzalez, A., Law, W.A., Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Science 217 (1982), 855–857.
44. Fernstrom, J.D., Role of precursor availability in control of monoamine biosynthesis in brain. Physiol. Rev. 63 (1983), 484–546.
45. Fleckenstein, A.E., Volz, T.J., Riddle, E.L., Gibb, J.W., Hanson, G.R., New insights into the mechanism of action of amphetamines. Annu. Rev. Pharmacol. Toxicol. 47 (2007), 681–698, 10.1146/annurev.pharmtox.47.120505.105140.
46. Folkersma, H., Boellaard, R., Vandertop, W.P., Kloet, R.W., Lubberink, M., Lammertsma, A.A., van Berckel, B.N.M., Reference tissue models and blood-brain barrier disruption: lessons from (R)-[11C]PK11195 in traumatic brain injury. J. Nucl. Med. 50 (2009), 1975–1979, 10.2967/jnumed.109.067512.
47. Forsyth, R., Jayamoni, B., Noradrenergic agonists for acute traumatic brain injury. Cochrane Database Syst. Rev., 1, 2003, CD003984.
48. Forsyth, R.J., Jayamoni, B., Paine, T.C., Monoaminergic agonists for acute traumatic brain injury. Cochrane Database Syst. Rev., 18, 2006, CD003984, 10.1002/14651858.CD003984.pub2.
49. Fuller, R.W., Pharmacology of brain epinephrine neurons. Annu. Rev. Pharmacol. Toxicol. 22 (1982), 31–55, 10.1146/annurev.pa.22.040182.000335.
50. Fuller, R.W., Mills, J., Marsh, M.M., Inhibition of phenethanolamine N-methyltransferase by ring-substituted.alpha.-methylphenethylamines (amphetamines). J. Med. Chem. 14 (1971), 322–325, 10.1021/jm00286a012.
51. Giacino, J.T., Whyte, J., Bagiella, E., Kalmar, K., Childs, N., Khademi, A., Eifert, B., Long, D., Katz, D.I., Cho, S., Yablon, S.A., Luther, M., Hammond, F.M., Nordenbo, A., Novak, P., Mercer, W., Maurer-Karattup, P., Sherer, M., Placebo-controlled trial of amantadine for severe traumatic brain injury. N Engl. J. Med. 366 (2012), 819–826, 10.1056/NEJMoa1102609.
52. Gianutsos, G., Chute, S., Dunn, J.P., Pharmacological changes in dopaminergic systems induced by long-term administration of amantadine. Eur. J. Pharmacol. 110 (1985), 357–361.
53. Goldstein, L.B., Neuropharmacology of TBI-induced plasticity. Brain Inj. 17 (2003), 685–694, 10.1080/0269905031000107179.
54. Goldstein, L.B., Bullman, S., Differential effects of haloperidol and clozapine on motor recovery after sensorimotor cortex injury in rats. Neurorehabil. Neural Repair 16 (2002), 321–325.
55. Granado, N., Ortiz, O., Suárez, L.M., Martín, E.D., Ceña, V., Solís, J.M., Moratalla, R., D1 but not D5 dopamine receptors are critical for LTP, spatial learning, and LTP-Induced arc and zif268 expression in the hippocampus. Cereb. Cortex 18 (2008), 1–12, 10.1093/cercor/bhm026.
56. Graybiel, A.M., Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 13 (1990), 244–254.
57. Griesbach, G.S., Hovda, D.A., Gomez-Pinilla, F., Sutton, R.L., Voluntary exercise or amphetamine treatment, but not the combination, increases hippocampal brain-derived neurotrophic factor and synapsin I following cortical contusion injury in rats. Neuroscience 154 (2008), 530–540, 10.1016/j.neuroscience.2008.04.003.
58. Gualtieri, C.T., Evans, R.W., Stimulant treatment for the neurobehavioural sequelae of traumatic brain injury. Brain Inj. 2 (1988), 273–290.
59. Gunne, L.M., Relative adrenaline content in brain tissue. Acta Physiol. Scand. 56 (1962), 324–333, 10.1111/j.1748-1716.1962.tb02509.x.
60. Haber, S.N., Fudge, J.L., McFarland, N.R., Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. J. Neurosci. 20 (2000), 2369–2382 doi:http://www.jneurosci.org/content/20/6/2369.
61. Haber, S.N., Kim, K.-S., Mailly, P., Calzavara, R., Reward-related cortical inputs define a large striatal region in primates that interface with associative cortical connections, providing a substrate for incentive-based learning. J. Neurosci. 26 (2006), 8368–8376, 10.1523/JNEUROSCI.0271-06.2006.
62. Haenggi, M., Andermatt, A., Anthamatten, C., Galimanis, A., Mono, M.-L., Alfieri, A., Fung, C., Takala, J., Jakob, S.M., CO(2)-dependent vasomotor reactivity of cerebral arteries in patients with severe traumatic brain injury: time course and effect of augmentation of cardiac output with dobutamine. J. Neurotrauma., 29, 2012, 10.1089/neu.2011.1809.
63. Hall, E.D., Andrus, P.K., Oostveen, J.A., Althaus, J.S., VonVoigtlander, P.F., Neuroprotective effects of the dopamine D2/D3 agonist pramipexole against postischemic or methamphetamine-induced degeneration of nigrostriatal neurons. Brain Res. 742 (1996), 80–88.
64. Hamill, R.W., Woolf, P.D., McDonald, J.V., Lee, L. a, Kelly, M., Catecholamines predict outcome in traumatic brain injury. Ann. Neurol. 21 (1987), 438–443, 10.1002/ana.410210504.
65. Hammond, F.M., Sherer, M., Malec, J.F., Zafonte, R.D., Whitney, M., Bell, K., Dikmen, S., Bogner, J., Mysiw, J., Pershad, R., Amantadine effect on perceptions of irritability after traumatic brain injury: results of the amantadine irritability multisite study. J. Neurotrauma, 9, 2015, 10.1089/neu.2014.3803.
66. Han, R.-Q., Ouyang, Y.-B., Xu, L., Agrawal, R., Patterson, A.J., Giffard, R.G., Postischemic brain injury is attenuated in mice lacking the beta2-adrenergic receptor. Anesth. Analg. 108 (2009), 280–287, 10.1213/ane.0b013e318187ba6b.
67. Henry, J.M., Talukder, N.K., Lee, A.B., Walker, M.L., Cerebral trauma-induced changes in corpus striatal dopamine receptor subtypes. J. Investig. Surg. 10 (1997), 281–286.
68. Hoffman, A., Cheng, J., Zafonte, R., Kline, A., Administration of haloperidol and risperidone after neurobehavioral testing hinders the recovery of traumatic brain injury-induced deficits. Life Sci. 83 (2008), 602–607, 10.1016/j.lfs.2008.08.007.
69. Hökfelt, T., Fuxe, K., Goldstein, M., Johansson, O., Evidence for adrenaline neurons in the rat brain. Acta Physiol. Scand. 89 (1973), 286–288, 10.1111/j.1748-1716.1973.tb05522.x.
70. Hovda, D.A., Sutton, R.L., Feeney, D.M., Amphetamine-induced recovery of visual cliff performance after bilateral visual cortex ablation in cats: measurements of depth perception thresholds. Behav. Neurosci. 103 (1989), 574–584.
71. Huang, E.Y.-K., Tsui, P.-F., Kuo, T.-T., Tsai, J.-J., Chou, Y.-C., Ma, H.-I., Chiang, Y.-H., Chen, Y.-H., Amantadine ameliorates dopamine-releasing deficits and behavioral deficits in rats after fluid percussion injury. Plos One, 9, 2014, e86354, 10.1371/journal.pone.0086354.
72. Huger, F., Patrick, G., Effect of concussive head injury on central catecholamine levels and synthesis rates in rat brain regions. J. Neurochem. 33 (1979), 89–95.
73. Hutson, C.B., Lazo, C.R., Mortazavi, F., Giza, C.C., Hovda, D., Chesselet, M.-F., Traumatic brain injury in adult rats causes progressive nigrostriatal dopaminergic cell loss and enhanced vulnerability to the pesticide paraquat. J. Neurotrauma 28 (2011), 1783–1801, 10.1089/neu.2010.1723.
74. Icard-Liepkalns, C., Berrard, S., Faucon Biguet, N., Lebourdelles, B., Ravassard, P., Robert, J.J., Mallet, J., Tyrosine hydroxylase regulation in neurotransmission and neuroplasticity. J. Physiol. Paris 87 (1993), 153–157.
75. Ikemoto, S., Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Res. Rev. 56 (2007), 27–78, 10.1016/j.brainresrev.2007.05.004.
76. Janssen, P.A., Niemegeers, C.J., Awouters, F., Schellekens, K.H., Megens, A.A., Meert, T.F., Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties. J. Pharmacol. Exp. Ther. 244 (1988), 685–693.
77. Jorge, R.E., Robinson, R.G., Moser, D., Tateno, A., Crespo-Facorro, B., Arndt, S., Major depression following traumatic brain injury. Arch. Gen. Psychiatry 61 (2004), 42–50, 10.1001/archpsyc.61.1.42.
78. Kaelin, D.L., Cifu, D.X., Matthies, B., Methylphenidate effect on attention deficit in the acutely brain-injured adult. Arch. Phys. Med. Rehabil. 77 (1996), 6–9.
79. Kahlig, K.M., Galli, A., Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine. Eur. J. Pharmacol. 479 (2003), 153–158.
80. Kanetani, K., Kimura, M., Endo, S., Therapeutic effects of milnacipran (serotonin noradrenalin reuptake inhibitor) on depression following mild and moderate traumatic brain injury. J. Nippon. Med. Sch. 70 (2003), 313–320.
81. Kang, S.H., Kim, D.-K., Drug induced parkinsonism caused by the concurrent use of donepezil and risperidone in a patient with traumatic brain injuries. Ann. Rehabil. Med. 37 (2013), 147–150, 10.5535/arm.2013.37.1.147.
82. Ker, K., Perel, P., Blackhall, K., Beta-2 receptor antagonists for traumatic brain injury: a systematic review of controlled trials in animal models. CNS Neurosci. Ther. 15 (2009), 52–64, 10.1111/j.1755-5949.2008.00069.x.
83. Kihara, T., Shimohama, S., Sawada, H., Honda, K., Nakamizo, T., Kanki, R., Yamashita, H., Akaike, A., Protective effect of dopamine D2 agonists in cortical neurons via the phosphatidylinositol 3 kinase cascade. J. Neurosci. Res. 70 (2002), 274–282, 10.1002/jnr.10426.
84. Kline, A., Massucci, J., Ma, X., Zafonte, R., Dixon, C., Bromocriptine reduces lipid peroxidation and enhances spatial learning and hippocampal neuron survival in a rodent model of focal brain trauma. J. Neurotrauma 21 (2004), 1712–1722, 10.1089/neu.2004.21.1712.
85. Kline, A., Massucci, J., Marion, D., Dixon, C., Attenuation of working memory and spatial acquisition deficits after a delayed and chronic bromocriptine treatment regimen in rats subjected to traumatic brain injury by controlled cortical impact. J. Neurotrauma 19 (2002), 415–425, 10.1089/08977150252932370.
86. Kline, A.E., Chen, M.J., Tso-Olivas, D.Y., Feeney, D.M., Methylphenidate treatment following ablation-induced hemiplegia in rat: experience during drug action alters effects on recovery of function. Pharmacol. Biochem. Behav. 48 (1994), 773–779.
87. Kline, A.E., Yan, H.Q., Bao, J., Marion, D.W., Dixon, C.E., Chronic methylphenidate treatment enhances water maze performance following traumatic brain injury in rats. Neurosci. Lett. 280 (2000), 163–166.
88. Kobori, N., Clifton, G.L., Dash, P.K., Enhanced catecholamine synthesis in the prefrontal cortex after traumatic brain injury: implications for prefrontal dysfunction. J. Neurotrauma 23 (2006), 1094–1102, 10.1089/neu.2006.23.1094.
89. Kobori, N., Hu, B., Dash, P.K., Altered adrenergic receptor signaling following traumatic brain injury contributes to working memory dysfunction. Neuroscience 172 (2011), 293–302, 10.1016/j.neuroscience.2010.10.048.
90. Konrad, K., Gauggel, S., Schurek, J., Catecholamine functioning in children with traumatic brain injuries and children with attention-deficit/hyperactivity disorder. Brain Res. Cognit. Brain Res 16 (2003), 425–433.
91. Kornhuber, J., Weller, M., Schoppmeyer, K., Riederer, P., Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties. J. Neural Transm. Suppl. 43 (1994), 91–104.
92. Kraus, M.F., Smith, G.S., Butters, M., Donnell, A.J., Dixon, E., Yilong, C., Marion, D., Effects of the dopaminergic agent and NMDA receptor antagonist amantadine on cognitive function, cerebral glucose metabolism and D2 receptor availability in chronic traumatic brain injury: a study using positron emission tomography (PET). Brain Inj. 19 (2005), 471–479.
93. Kriz, J., Inflammation in ischemic brain injury: timing is important. Crit. Rev. Neurobiol. 18 (2006), 145–157.
94. Ladanyi, S., Elliott, D., Traumatic brain injury: an integrated clinical case presentation and literature review. Part I: assessment and initial management. Aust. Crit. Care 21 (2008), 86–95, 10.1016/j.aucc.2008.02.001.
95. Lang, Y., Fu, F., Sun, D., Xi, C., Chen, F., Labetalol prevents intestinal dysfunction induced by traumatic brain injury. Plos One, 10, 2015, e0133215, 10.1371/journal.pone.0133215.
96. Lee, H., Kim, S.-W., Kim, J.-M., Shin, I.-S., Yang, S.-J., Yoon, J.-S., Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury. Hum. Phychopharmacol. 20 (2005), 97–104, 10.1002/hup.668.
97. Levin, B.E., Brown, K.L., Pawar, G., Dunn-Meynell, A., Widespread and lateralization effects of acute traumatic brain injury on norepinephrine turnover in the rat brain. Brain Res. 674 (1995), 307–313.
98. Lifshitz, J., Witgen, B.M., Grady, M.S., Acute cognitive impairment after lateral fluid percussion brain injury recovers by 1 month: evaluation by conditioned fear response. Behav. Brain Res. 177 (2007), 347–357, 10.1016/j.bbr.2006.11.014.
99. M'Harzi, M., Willig, F., Costa, J.C., Delacour, J., d-Amphetamine enhances memory performance in rats with damage to the fimbria. Physiol. Behav. 42 (1988), 575–579.
100. Maeda, T., Lee, S.M., Hovda, D.A., Restoration of cerebral vasoreactivity by an L-type calcium channel blocker following fluid percussion brain injury. J. Neurotrauma 22 (2005), 763–771, 10.1089/neu.2005.22.763.
101. Mahesh, R., Pandey, D.K., Katiyar, S., Kukade, G., Viyogi, S., Rudra, A., Effect of anti-depressants on neuro-behavioural consequences following impact accelerated traumatic brain injury in rats. Indian J. Exp. Biol. 48 (2010), 466–473.
102. Massucci, J., Kline, A., Ma, X., Zafonte, R., Dixon, C., Time dependent alterations in dopamine tissue levels and metabolism after experimental traumatic brain injury in rats. Neurosci. Lett. 372 (2004), 127–131, 10.1016/j.neulet.2004.09.026.
103. Mautes, A.E., Müller, M., Cortbus, F., Schwerdtfeger, K., Maier, B., Holanda, M., Nacimiento, A., Marzi, I., Steudel, W.I., Alterations of norepinephrine levels in plasma and CSF of patients after traumatic brain injury in relation to disruption of the blood-brain barrier. Acta Neurochir. (Wien.) 143 (2001), 51–57, 10.1007/s007010170138.
104. McAllister, T.W., Flashman, L.A., McDonald, B.C., Ferrell, R.B., Tosteson, T.D., Yanofsky, N.N., Grove, M.R., Saykin, A.J., Dopaminergic challenge with bromocriptine one month after mild traumatic brain injury: altered working memory and BOLD response. J. Neuropsychiatry Clin. Neurosci. 23 (2011), 277–286, 10.1176/appi.neuropsych.23.3.277.
105. McDowell, S., Whyte, J., D'Esposito, M., Differential effect of a dopaminergic agonist on prefrontal function in traumatic brain injury patients. Brain 121:Pt 6 (1998), 1155–1164.
106. McIntosh, T.K., Yu, T., Gennarelli, T.A., Alterations in regional brain catecholamine concentrations after experimental brain injury in the rat. J. Neurochem. 63 (1994), 1426–1433.
107. Meythaler, J., Depalma, L., Devivo, M., Guin-Renfroe, S., Novack, T., Sertraline to improve arousal and alertness in severe traumatic brain injury secondary to motor vehicle crashes. Brain Inj. 15 (2001), 321–331, 10.1080/026990501750111274.
108. Meythaler, J.M., Peduzzi, J.D., Eleftheriou, E., Novack, T.A., Current concepts: diffuse axonal injury–associated traumatic brain injury. Arch. Phys. Med. Rehabil. 82 (2001), 1461–1471, 10.1053/apmr.2001.25137.
109. Milner, J.D., Wurtman, R.J., Catecholamine synthesis: physiological coupling to precursor supply. Biochem. Pharmacol. 35 (1986), 875–881.
110. Misu, Y., Goshima, Y., Is L-dopa an endogenous neurotransmitter?. Trends Pharmacol. Sci. 14 (1993), 119–123.
111. Mitchell, J.B., Gratton, A., Involvement of mesolimbic dopamine neurons in sexual behaviors: implications for the neurobiology of motivation. Rev. Neurosci. 5 (1994), 317–329.
112. Moe, R.O., Nordgreen, J., Janczak, A.M., Spruijt, B.M., Kostal, L., Skjerve, E., Zanella, A.J., Bakken, M., Effects of haloperidol, a dopamine D2-like receptor antagonist, on reward-related behaviors in laying hens. Physiol. Behav. 102 (2011), 400–405, 10.1016/j.physbeh.2010.12.008.
113. Moldover, J.E., Goldberg, K.B., Prout, M.F., Depression after traumatic brain injury: a review of evidence for clinical heterogeneity. Neuropsychol. Rev. 14 (2004), 143–154.
114. Mooney, G.F., Haas, L.J., Effect of methylphenidate on brain injury-related anger. Arch. Phys. Med. Rehabil. 74 (1993), 153–160.
115. Muir, K.W., Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists. Curr. Opin. Phamacol. 6 (2006), 53–60, 10.1016/j.coph.2005.12.002.
116. Mura, A., Feldon, J., Spatial learning in rats is impaired after degeneration of the nigrostriatal dopaminergic system. Mov. Disord. 18 (2003), 860–871, 10.1002/mds.10472.
117. Nagatsu, T., Mogi, M., Ichinose, H., Togari, A., Changes in cytokines and neurotrophins in Parkinso's disease. J. Neural Transm. Suppl. 60 (2000), 277–290.
118. Nair, V.D., Sealfon, S.C., Agonist-specific transactivation of phosphoinositide 3-kinase signaling pathway mediated by the dopamine D2 receptor. J. Biol. Chem. 278 (2003), 47053–47061, 10.1074/jbc.M303364200.
119. National Institute of Neurological Diseases and Stroke, 2015. Traumatic Brain Injury [WWW Document]. NINDS Common Data Elem. Harmon. Information. Streamlining Reearch. URL 〈http://www.commondataelements.ninds.nih.gov/tbi.aspx#tab=Data_Standards〉.
120. Nieoullon, A., Dopamine and the regulation of cognition and attention. Prog. Neurobiol. 67 (2002), 53–83, 10.1016/S0301-0082(02)00011-4.
121. NIH, 1998. Rehabilitation of persons with traumatic brain injury. NIH Consens. Statement, 16. pp. 1–41.
122. Novack, T.A., Baños, J.H., Brunner, R., Renfroe, S., Meythaler, J.M., Impact of early administration of sertraline on depressive symptoms in the first year after traumatic brain injury. J. Neurotrauma 26 (2009), 1921–1928, 10.1089/neu.2009.0895.
123. O'Carroll, C.M., Martin, S.J., Sandin, J., Frenguelli, B., Morris, R.G.M., Dopaminergic modulation of the persistence of one-trial hippocampus-dependent memory. Learn. Mem. 13 (2006), 760–769, 10.1101/lm.321006.
124. Oddy, M., Coughlan, T., Tyerman, A., Jenkins, D., Social adjustment after closed head injury: a further follow-up seven years after injury. J. Neurol. Neurosurg. Psychiatry 48 (1985), 564–568.
125. Okada, Y., Sakai, H., Kohiki, E., Suga, E., Yanagisawa, Y., Tanaka, K., Hadano, S., Osuga, H., Ikeda, J.-E., A dopamine D4 receptor antagonist attenuates ischemia-induced neuronal cell damage via upregulation of neuronal apoptosis inhibitory protein. J. Cereb. Blood Flow Metab. 25 (2005), 794–806, 10.1038/sj.jcbfm.9600078.
126. Patrick, P.D., Blackman, J.A., Mabry, J.L., Buck, M.L., Gurka, M.J., Conaway, M.R., Dopamine agonist therapy in low-response children following traumatic brain injury. J. Child Neurol. 21 (2006), 879–885.
127. Pavlovskaya, M., Hochstein, S., Keren, O., Mordvinov, E., Groswasser, Z., Methylphenidate effect on hemispheric attentional imbalance in patients with traumatic brain injury: a psychophysical study. Brain Inj. 21 (2007), 489–497, 10.1080/02699050701311117.
128. Peet, A., Lieberman, M.A., Marks, A.M., Marks׳ Basic Medical Biochemistry: A Clinical Approach. 4th ed., 2013, Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, PA, USA.
129. Perry, B., Stolk, J., Vantini, G., Guchhait, R., U'Prichard, D., Strain differences in rat brain epinephrine synthesis: regulation of alpha-adrenergic receptor number by epinephrine. Science 221:4617 (1983), 1297–1299, 10.1126/science.6310752.
130. Piercey, M.F., Pharmacology of pramipexole, a dopamine D3-preferring agonist useful in treating Parkinson׳s disease. Clin. Neuropharmacol. 21 (1998), 141–151.
131. Plenger, P.M., Dixon, C.E., Castillo, R.M., Frankowski, R.F., Yablon, S.A., Levin, H.S., Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: a preliminary double-blind placebo-controlled study. Arch. Phys. Med. Rehabil. 77 (1996), 536–540.
132. Ploeger, G.E., Spruijt, B.M., Cools, A.R., Spatial localization in the Morris water maze in rats: acquisition is affected by intra-accumbens injections of the dopaminergic antagonist haloperidol. Behav. Neurosci. 108 (1994), 927–934.
133. Ploeger, G.E., Willemen, A.P., Cools, A.R., Role of the nucleus accumbens in social memory in rats. Brain Res. Bull. 26 (1991), 23–27.
134. Pohorecky, L.A., Baliga, B.S., Purification and properties of rat adrenal phenylethanolamine-N-methyl transferase. Arch. Biochem. Biophys. 156 (1973), 703–711.
135. Pohorecky, L.A., Zigmond, M., Karten, H., Wurtman, R.J., Enzymatic conversion of norepinephrine to epinephrine by the brain. J. Pharmacol. Exp. Ther. 165 (1969), 190–195.
136. Queen, S.A., Chen, M.J., Feeney, D.M., d-Amphetamine attenuates decreased cerebral glucose utilization after unilateral sensorimotor cortex contusion in rats. Brain Res. 777 (1997), 42–50.
137. Ramic, M., Emerick, A.J., Bollnow, M.R., O'Brien, T.E., Tsai, S.-Y., Kartje, G.L., Axonal plasticity is associated with motor recovery following amphetamine treatment combined with rehabilitation after brain injury in the adult rat. Brain Res. 1111 (2006), 176–186, 10.1016/j.brainres.2006.06.063.
138. Ratcliff, J.J., Greenspan, A.I., Goldstein, F.C., Stringer, A.Y., Bushnik, T., Hammond, F.M., Novack, T.A., Whyte, J., Wright, D.W., Gender and traumatic brain injury: do the sexes fare differently?. Brain Inj. 21 (2007), 1023–1030, 10.1080/02699050701633072.
139. Rau, T.F., Kothiwal, A.S., Rova, A.R., Brooks, D.M., Poulsen, D.J., Treatment with low-dose methamphetamine improves behavioral and cognitive function after severe traumatic brain injury. J. Trauma Acute Care Surg. 73 (2012), S165–S172, 10.1097/TA.0b013e318260896a.
140. Redell, J.B., Dash, P.K., Traumatic brain injury stimulates hippocampal catechol-O-methyl transferase expression in microglia. Neurosci. Lett. 413 (2007), 36–41, 10.1016/j.neulet.2006.11.060.
141. Reeves, T.M., Phillips, L.L., Lee, N.N., Povlishock, J.T., Preferential neuroprotective effect of tacrolimus (FK506) on unmyelinated axons following traumatic brain injury. Brain Res. 1154 (2007), 225–236, 10.1016/j.brainres.2007.04.002.
142. Ridley, R.M., Cummings, R.M., Leow-Dyke, A., Baker, H.F., Neglect of memory after dopaminergic lesions in monkeys. Behav. Brain Res. 166 (2006), 253–262, 10.1016/j.bbr.2005.08.007.
143. Rosner, M.J., Newsome, H.H., Becker, D.P., Mechanical brain injury: the sympathoadrenal response. J. Neurosurg. 61 (1984), 76–86, 10.3171/jns.1984.61.1.0076.
144. Salamone, J.D., The involvement of nucleus accumbens dopamine in appetitive and aversive motivation. Behav. Brain Res. 61 (1994), 117–133.
145. Salamone, J.D., Correa, M., Mingote, S.M., Weber, S.M., Beyond the reward hypothesis: alternative functions of nucleus accumbens dopamine. Curr. Opin. Phamacol. 5 (2005), 34–41, 10.1016/j.coph.2004.09.004.
146. Sall, D.J., Grunewald, G.L., Inhibition of phenylethanolamine N-methyltransferase (PNMT) by aromatic hydroxy-substituted 1,2,3,4-tetrahydroisoquinolines. Further studies on the hydrophilic pocket of the aromatic ring binding region of the active site. J. Med. Chem. 30 (1987), 2208–2216, 10.1021/jm00395a006.
147. Saniova, B., Drobny, M., Kneslova, L., Minarik, M., The outcome of patients with severe head injuries treated with amantadine sulphate. J. Neural Transm. 111 (2004), 511–514, 10.1007/s00702-004-0112-4.
148. Schapira, A.H.V., Neuroprotection in Parkinson׳s disease. Park. Relat. Disord. 15:Suppl. 4 (2009), S41–S43, 10.1016/S1353-8020(09)70834-X.
149. Schiffer, W.K., Volkow, N., Fowler, J.S., Alexoff, D.L., Logan, J., Dewey, S.L., Therapeutic doses of amphetamine or methylphenidate differentially increase synaptic and extracellular dopamine. Synapse 59 (2006), 243–251, 10.1002/syn.20235.
150. Schroeppel, T.J., Fischer, P.E., Zarzaur, B.L., Magnotti, L.J., Clement, L.P., Fabian, T.C., Croce, M.A., Beta-adrenergic blockade and traumatic brain injury: protective?. J. Trauma 69 (2010), 776–782, 10.1097/TA.0b013e3181e981b8.
151. Seamans, J.K., Yang, C.R., The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog. Neurobiol. 74 (2004), 1–57, 10.1016/j.pneurobio.2004.05.006.
152. Seel, R.T., Kreutzer, J.S., Rosenthal, M., Hammond, F.M., Corrigan, J.D., Black, K., Depression after traumatic brain injury: a national institute on disability and rehabilitation research model systems multicenter investigation. Arch. Phys. Med. Rehabil. 84 (2003), 177–184, 10.1053/apmr.2003.50106.
153. Setlow, B., McGaugh, J.L., Sulpiride infused into the nucleus accumbens posttraining impairs memory of spatial water maze training. Behav. Neurosci. 112 (1998), 603–610.
154. Shen, H., Harvey, B.K., Chiang, Y.-H., Pick, C.G., Wang, Y., Methamphetamine potentiates behavioral and electrochemical responses after mild traumatic brain injury in mice. Brain Res. 1368 (2011), 248–253, 10.1016/j.brainres.2010.10.014.
155. Shin, S.S., Bales, J.W., Yan, H.Q., Kline, A.E., Wagner, A.K., Lyons-Weiler, J., Dixon, C.E., The effect of environmental enrichment on substantia nigra gene expression after traumatic brain injury in rats. J. Neurotrauma 30 (2013), 259–270, 10.1089/neu.2012.2462.
156. Shin, S.S., Bray, E.R., Dixon, C.E., Effects of nicotine administration on striatal dopamine signaling after traumatic brain injury in rats. J. Neurotrauma 29 (2012), 843–850, 10.1089/neu.2011.1966.
157. Slewa-Younan, S., Green, A.M., Baguley, I.J., Gurka, J.A., Marosszeky, J.E., Sex differences in injury severity and outcome measures after traumatic brain injury. Arch. Phys. Med. Rehabil. 85 (2004), 376–379.
158. Smith D.H., Hicks R.R., Johnson V.E., Bergstrom D.A., Cummings D.M., NobleL.J., Hovda D., Whalen M., Ahlers S.T., LaPlaca M., Tortella F.C., Duhaime A.C. and Dixon C.E., Pre-clinical traumatic brain injury common data elements: toward a common language across laboratories, J. Neurotrauma 32, 2015, 1725-1735, http://dx.doi.org/10.1089/neu.2014.3861.
159. Sonuga-Barke, E.J.S., Causal models of attention-deficit/hyperactivity disorder: from common simple deficits to multiple developmental pathways. Biol. Psyciatry 57 (2005), 1231–1238, 10.1016/j.biopsych.2004.09.008.
160. Sookplung, P., Siriussawakul, A., Malakouti, A., Sharma, D., Wang, J., Souter, M.J., Chesnut, R.M., Vavilala, M.S., Vasopressor use and effect on blood pressure after severe adult traumatic brain injury. Neurocrit. Care 15 (2011), 46–54.
161. Speech, T.J., Rao, S.M., Osmon, D.C., Sperry, L.T., A double-blind controlled study of methylphenidate treatment in closed head injury. Brain Inj. 7 (1993), 333–338.
162. Spritzer, S.D., Kinney, C.L., Condie, J., Wellik, K.E., Hoffman-Snyder, C.R., Wingerchuk, D.M., Demaerschalk, B.M., Amantadine for patients with severe traumatic brain injury: a critically appraised topic. Neurologist 19 (2015), 61–64, 10.1097/NRL.0000000000000001.
163. Stahl, S.M., Pradko, J.F., Haight, B.R., Modell, J.G., Rockett, C.B., Learned-Coughlin, S., A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. Prim. Care Companion J. Clin. Psychiatry 6 (2004), 159–166.
164. Stanislav, S.W., Cognitive effects of antipsychotic agents in persons with traumatic brain injury. Brain Inj. 11 (1997), 335–342, 10.1080/026990597123494.
165. Stelmaschuk, S., Will, M.C., Meyers, T., Amantadine to treat cognitive dysfunction in moderate to severe traumatic brain injury. J. Trauma Nurs. 22 (2015), 194–203, 10.1097/JTN.0000000000000138.
166. Stover, J.F., Sakowitz, O.W., Schöning, B., Rupprecht, S., Kroppenstedt, S.N., Thomale, U.W., Woiciechowsky, C., Unterberg, A.W., Norepinephrine infusion increases interleukin-6 in plasma and cerebrospinal fluid of brain-injured rats. Med. Sci. Monit. 9 (2003), BR382–BR388.
167. Sun Z.-L., Feng D.-F., Biomarkers of cognitive dysfunction in traumatic brain injury, J. Neural Transm. 12, 2013, 79-90, http://dx.doi.org/10.1007/s00702-013-1078-x.
168. Sutton, M.A., Beninger, R.J., Psychopharmacology of conditioned reward: evidence for a rewarding signal at D1-like dopamine receptors. Psychopharmacology 144 (1999), 95–110.
169. Tamaru, F., Disturbances in higher function in Parkinson׳s disease. Eur. Neurol. 38 Suppl 2 (1997), S33–S36.
170. Tang, W.K., Chen, Y.K., Mok, V., Chu, W.C.W., Ungvari, G.S., Ahuja, A.T., Wong, K.S., Acute basal ganglia infarcts in poststroke fatigue: an MRI study. J. Neurol. 257 (2010), 178–182, 10.1007/s00415-009-5284-2.
171. Tang, W.K., Liang, H.J., Chen, Y.K., Chu, W.C.W., Abrigo, J., Mok, V.C.T., Ungvari, G.S., Wong, K.S., Poststroke fatigue is associated with caudate infarcts. J. Neurol. Sci. 324 (2013), 131–135, 10.1016/j.jns.2012.10.022.
172. Tang, Y.P., Noda, Y., Nabeshima, T., Involvement of activation of dopaminergic neuronal system in learning and memory deficits associated with experimental mild traumatic brain injury. Eur. J. Neurosci. 9 (1997), 1720–1727.
173. Thurman, D.J., Alverson, C., Dunn, K.A., Guerrero, J., Sniezek, J.E., Traumatic brain injury in the United States: A public health perspective. J. Head Trauma Rehabil. 14 (1999), 602–615.
174. Tidey, J.W., Miczek, K.A., Social defeat stress selectively alters mesocorticolimbic dopamine release: an in vivo microdialysis study. Brain Res. 721 (1996), 140–149.
175. Tolias, C.M., Bullock, M.R., Critical appraisal of neuroprotection trials in head injury: what have we learned?. NeuroRx 1 (2004), 71–79, 10.1602/neurorx.1.1.71.
176. Toth, M., Ziegler, M., Sun, P., Gresack, J., Risbrough, V., Impaired conditioned fear response and startle reactivity in epinephrine-deficient mice. Behav. Pharmacol. 24 (2013), 1–9, 10.1097/FBP.0b013e32835cf408.
177. Tran, T.Y., Dunne, I.E., German, J.W., Beta blockers exposure and traumatic brain injury: a literature review. Neurosurg. Focus, 25, 2008, E8, 10.3171/FOC.2008.25.10.E8.
178. Tschuor, C., Asmis, L.M., Lenzlinger, P.M., Tanner, M., Härter, L., Keel, M., Stocker, R., Stover, J.F., In vitro norepinephrine significantly activates isolated platelets from healthy volunteers and critically ill patients following severe traumatic brain injury. Crit. Care, 12, 2008, R80, 10.1186/cc6931.
179. Udy, A., Boots, R., Senthuran, S., Stuart, J., Deans, R., Lassig-Smith, M., Lipman, J., Augmented creatinine clearance in traumatic brain injury. Anesth. Analg. 111 (2010), 1505–1510, 10.1213/ANE.0b013e3181f7107d.
180. Vallone, D., Picetti, R., Borrelli, E., Structure and function of dopamine receptors. Neurosci. Biobehav. Rev. 24 (2000), 125–132, 10.1016/S0149-7634(99)00063-9.
181. Vertes, R.P., Interactions among the medial prefrontal cortex, hippocampus and midline thalamus in emotional and cognitive processing in the rat. Neuroscience 142 (2006), 1–20, 10.1016/j.neuroscience.2006.06.027.
182. Viggiano, D., Vallone, D., Ruocco, L.A., Sadile, A.G., Behavioural, pharmacological, morpho-functional molecular studies reveal a hyperfunctioning mesocortical dopamine system in an animal model of attention deficit and hyperactivity disorder. Neurosci. Biobehav. Rev. 27 (2003), 683–689.
183. Vogt, M., The concentration of sympathin in different parts of the central nervous system under normal conditions and after the administration of drugs. J. Physiol. 123 (1954), 451–481.
184. Volkow, N., Fowler, J.S., Wang, G., Ding, Y., Gatley, S.J., Mechanism of action of methylphenidate: insights from PET imaging studies. J. Atten. Disord. 6:Suppl. 1 (2002), S31–S43.
185. Volkow, N., Wang, G.J., Fowler, J.S., Gatley, S.J., Logan, J., Ding, Y.S., Hitzemann, R., Pappas, N., Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am. J. Psychiatry 155 (1998), 1325–1331.
186. Volkow, N., Wang, G.-J., Fowler, J.S., Logan, J., Franceschi, D., Maynard, L., Ding, Y.-S., Gatley, S.J., Gifford, A., Zhu, W., Swanson, J.M., Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications. Synapse 43 (2002), 181–187, 10.1002/syn.10038.
187. Volkow, N., Wang, G.-J., Fowler, J.S., Telang, F., Maynard, L., Logan, J., Gatley, S.J., Pappas, N., Wong, C., Vaska, P., Zhu, W., Swanson, J.M., Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain. Am. J. Psychiatry 161 (2004), 1173–1180.
188. Volz, T.J., Neuropharmacological mechanisms underlying the neuroprotective effects of methylphenidate. Curr. Neuropharmacol. 6 (2008), 379–385, 10.2174/157015908787386041.
189. Von Bohlen und Halbach, O., Dermietzel, R., Neurotransmitters and Neuromodulators: Handbook of Receptors and Biological Effects, 2006, Wiley.
190. Von Voigtlander, P.F., Moore, K.E., Dopamine: release from the brain in vivo by amantadine. Science 174:80 (1971), 408–410.
191. Wagner, A., Ren, D., Conley, Y., Ma, X., Kerr, M., Zafonte, R., Puccio, A., Marion, D., Dixon, C., Sex and genetic associations with cerebrospinal fluid dopamine and metabolite production after severe traumatic brain injury. J. Neurosurg. 106 (2007), 538–547, 10.3171/jns.2007.106.4.538.
192. Wagner, A.K., Chen, X., Kline, A.E., Li, Y., Zafonte, R.D., Dixon, C.E., Gender and environmental enrichment impact dopamine transporter expression after experimental traumatic brain injury. Exp. Neurol. 195 (2005), 475–483, 10.1016/j.expneurol.2005.06.009.
193. Wagner, A.K., Drewencki, L.L., Chen, X., Santos, F.R., Khan, A.S., Harun, R., Torres, G.E., Michael, A.C., Dixon, C.E., Chronic methylphenidate treatment enhances striatal dopamine neurotransmission after experimental traumatic brain injury. J. Neurochem. 108 (2009), 986–997, 10.1111/j.1471-4159.2008.05840.x.
194. Wagner, A.K., Sokoloski, J.E., Ren, D., Chen, X., Khan, A.S., Zafonte, R.D., Michael, A.C., Dixon, C.E., Controlled cortical impact injury affects dopaminergic transmission in the rat striatum. J. Neurochem. 95 (2005), 457–465, 10.1111/j.1471-4159.2005.03382.x.
195. Wang T., Huang X.J., Van K.C., Went G.T., Nguyen J.T., Lyeth B.G., Amantadine improves cognitive outcome and increases neuronal survival after fluid percussion traumatic brain injury in rats, J. Neurotrauma 31, 2013, http://dx.doi.org/10.1089/neu.2013.2917.
196. Wang, Y., Neumann, M., Hansen, K., Hong, S.M., Kim, S., Noble-Haeusslein, L.J., Liu, J., Fluoxetine increases hippocampal neurogenesis and induces epigenetic factors but does not improve functional recovery after traumatic brain injury. J. Neurotrauma 28 (2011), 259–268, 10.1089/neu.2010.1648.
197. Warden, D.L., Gordon, B., McAllister, T.W., Silver, J.M., Barth, J.T., Bruns, J., Drake, A., Gentry, T., Jagoda, A., Katz, D.I., Kraus, J., Labbate, L.A., Ryan, L.M., Sparling, M.B., Walters, B., Whyte, J., Zapata, A., Zitnay, G., Guidelines for the pharmacologic treatment of neurobehavioral sequelae of traumatic brain injury. J. Neurotrauma 23 (2006), 1468–1501, 10.1089/neu.2006.23.1468.
198. Whalen, M.J., Carlos, T.M., Kochanek, P.M., Heineman, S., Blood-brain barrier permeability, neutrophil accumulation and vascular adhesion molecule expression after controlled cortical impact in rats: a preliminary study. Acta Neurochir. Suppl. 71 (1998), 212–214.
199. Whyte, J., Hart, T., Vaccaro, M., Grieb-Neff, P., Risser, A., Polansky, M., Coslett, H.B., Effects of methylphenidate on attention deficits after traumatic brain injury: a multidimensional, randomized, controlled trial. Am. J. Phys. Med. Rehabil. 83 (2004), 401–420.
200. Wickens, J.R., Budd, C.S., Hyland, B.I., Arbuthnott, G.W., Striatal contributions to reward and decision making: making sense of regional variations in a reiterated processing matrix. Ann. N.Y. Acad. Sci. 1104 (2007), 192–212, 10.1196/annals.1390.016.
201. Woolf, P.D., Hamill, R.W., Lee, L.A., Cox, C., McDonald, J., The predictive value of catecholamines in assessing outcome in traumatic brain injury. J. Neurosurg. 66 (1987), 875–882, 10.3171/jns.1987.66.6.0875.
202. Yamamoto, Y., Tanaka, T., Shibata, S., Watanabe, S., Involvement of D1 dopamine receptor mechanism in ischemia-induced impairment of CA1 presynaptic fiber spikes in rat hippocampal slices. Brain Res. 665 (1994), 151–154.
203. Yue, J.K., Winkler, E.A., McAllister, T.W., Temkin, N., Ferguson, A., Lingsma, H.F., Yuh, E., Tarapore, P.E., Sharma, S., Puccio, A., Wang, K., Mukherjee, P., Valadka, A.B., Okonkwo, D.O., Diaz-Arrastia, R., Manley, G.T., 178 COMT Val158Met is associated with domain-specific cognitive impairment following mild traumatic brain injury. Neurosurgery, 62(Suppl. 1), 2015, S225, 10.1227/01.neu.0000467142.58514.77.
204. Zhuang, X., Oosting, R.S., Jones, S.R., Gainetdinov, R.R., Miller, G.W., Caron, M.G., Hen, R., Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proc. Natl. Acad. Sci. USA 98 (2001), 1982–1987, 10.1073/pnas.98.4.1982.
205. Zou, S., Li, L., Pei, L., Vukusic, B., Van Tol, H.H.M., Lee, F.J.S., Wan, Q., Liu, F., Protein-protein coupling/uncoupling enables dopamine D2 receptor regulation of AMPA receptor-mediated excitotoxicity. J. Neurosci. 25 (2005), 4385–4395, 10.1523/JNEUROSCI.5099-04.2005.
206. Zweckberger, K., Simunovic, F., Kiening, K.L., Unterberg, A.W., Sakowitz, O.W., Anticonvulsive effects of the dopamine agonist lisuride maleate after experimental traumatic brain injury. Neurosci. Lett. 470 (2010), 150–154, 10.1016/j.neulet.2009.12.075.